Author Correction: Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig
Yulia Rubanova(Simon Fraser University), Iñigo Martincorena(Wellcome Sanger Institute), Paul C. Boutros(University of California, Los Angeles), Clemency Jolly(The Francis Crick Institute), Marcin Imieliński(NYU Langone Health), Ruben M. Drews(GlaxoSmithKline (United Kingdom)), Jonas Demeulemeester(The Francis Crick Institute), Marek Cmero(The Royal Melbourne Hospital), David D.L. Bowtell(The University of Melbourne), Peter J. Campbell(Wellcome Sanger Institute), Kortine Kleinheinz(German Cancer Research Center), Elizabeth L. Christie(Peter MacCallum Cancer Centre), Henry Lee-Six(Great Ormond Street Hospital), Gavin Ha(AstraZeneca (United Kingdom)), Roland Eils(Heidelberg University), Pavana Anur, Salem Malikić(Simon Fraser University), Geoff Macintyre(The University of Melbourne), Shaolong Cao(The University of Texas MD Anderson Cancer Center), Amit G. Deshwar(Ontario Genomics), Caitlin F. Harrigan(University of Toronto), Kaixian Yu(European Bioinformatics Institute), Ignaty Leshchiner(Broad Institute), Lara Jerman(Endeavor Health), Santiago González(Barcelona Supercomputing Center), Matthew W. Fittall(University College Hospital), Yupeng Cun(Children's Hospital of Chongqing Medical University), Roujia Li(University of Toronto), Kerstin Haase(The Francis Crick Institute), Florian Markowetz(Cancer Research UK), Jeff Wintersinger(University of Toronto), David J. Adams(Wellcome Sanger Institute), Nil Sahin(University of Toronto), Kevin J. Dawson(Wellcome Sanger Institute), Gad Getz(Broad Institute), Rameen Beroukhim(Broad Institute), Dimitri Livitz(Broad Institute)
Cited by 0
Related Papers
Integrative genomics viewer
|Nature Biotechnology|2011|16.5k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k